Global Extended Release Drug Market Growth (Status and Outlook) 2025-2031

September 2025 | 83 pages | ID: GE8090A31DA3EN
LP Information

Abstracts

According to this study, the global Extended Release Drug market size will reach US$ million by 2031.

Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Extended Release Drug Industry Forecast” looks at past sales and reviews total world Extended Release Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Extended Release Drug sales for 2025 through 2031. With Extended Release Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extended Release Drug industry.

This Insight Report provides a comprehensive analysis of the global Extended Release Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Extended Release Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extended Release Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extended Release Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extended Release Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Extended Release Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Sustained Release Drug
• Controlled Release Drug

Segmentation by Application:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Mallinckrodt
• Teva
• Johnson & Johnson
• Endo Pharmaceuticals
• Purdue Pharma
• Mylan
• Hisamitsu Pharmaceutical
• Sun Pharmaceutical Industries

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Extended Release Drug Market Size (2020-2031)
  2.1.2 Extended Release Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Extended Release Drug by Country/Region (2020, 2024 & 2031)
2.2 Extended Release Drug Segment by Type
  2.2.1 Sustained Release Drug
  2.2.2 Controlled Release Drug
2.3 Extended Release Drug Market Size by Type
  2.3.1 Extended Release Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Extended Release Drug Market Size Market Share by Type (2020-2025)
2.4 Extended Release Drug Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Online Pharmacy
2.5 Extended Release Drug Market Size by Application
  2.5.1 Extended Release Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Extended Release Drug Market Size Market Share by Application (2020-2025)

3 EXTENDED RELEASE DRUG MARKET SIZE BY PLAYER

3.1 Extended Release Drug Market Size Market Share by Player
  3.1.1 Global Extended Release Drug Revenue by Player (2020-2025)
  3.1.2 Global Extended Release Drug Revenue Market Share by Player (2020-2025)
3.2 Global Extended Release Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EXTENDED RELEASE DRUG BY REGION

4.1 Extended Release Drug Market Size by Region (2020-2025)
4.2 Global Extended Release Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Extended Release Drug Market Size Growth (2020-2025)
4.4 APAC Extended Release Drug Market Size Growth (2020-2025)
4.5 Europe Extended Release Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Extended Release Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Extended Release Drug Market Size by Country (2020-2025)
5.2 Americas Extended Release Drug Market Size by Type (2020-2025)
5.3 Americas Extended Release Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Extended Release Drug Market Size by Region (2020-2025)
6.2 APAC Extended Release Drug Market Size by Type (2020-2025)
6.3 APAC Extended Release Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Extended Release Drug Market Size by Country (2020-2025)
7.2 Europe Extended Release Drug Market Size by Type (2020-2025)
7.3 Europe Extended Release Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Extended Release Drug by Region (2020-2025)
8.2 Middle East & Africa Extended Release Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Extended Release Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EXTENDED RELEASE DRUG MARKET FORECAST

10.1 Global Extended Release Drug Forecast by Region (2026-2031)
  10.1.1 Global Extended Release Drug Forecast by Region (2026-2031)
  10.1.2 Americas Extended Release Drug Forecast
  10.1.3 APAC Extended Release Drug Forecast
  10.1.4 Europe Extended Release Drug Forecast
  10.1.5 Middle East & Africa Extended Release Drug Forecast
10.2 Americas Extended Release Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Extended Release Drug Forecast
  10.2.2 Canada Market Extended Release Drug Forecast
  10.2.3 Mexico Market Extended Release Drug Forecast
  10.2.4 Brazil Market Extended Release Drug Forecast
10.3 APAC Extended Release Drug Forecast by Region (2026-2031)
  10.3.1 China Extended Release Drug Market Forecast
  10.3.2 Japan Market Extended Release Drug Forecast
  10.3.3 Korea Market Extended Release Drug Forecast
  10.3.4 Southeast Asia Market Extended Release Drug Forecast
  10.3.5 India Market Extended Release Drug Forecast
  10.3.6 Australia Market Extended Release Drug Forecast
10.4 Europe Extended Release Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Extended Release Drug Forecast
  10.4.2 France Market Extended Release Drug Forecast
  10.4.3 UK Market Extended Release Drug Forecast
  10.4.4 Italy Market Extended Release Drug Forecast
  10.4.5 Russia Market Extended Release Drug Forecast
10.5 Middle East & Africa Extended Release Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Extended Release Drug Forecast
  10.5.2 South Africa Market Extended Release Drug Forecast
  10.5.3 Israel Market Extended Release Drug Forecast
  10.5.4 Turkey Market Extended Release Drug Forecast
10.6 Global Extended Release Drug Forecast by Type (2026-2031)
10.7 Global Extended Release Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Extended Release Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Extended Release Drug Product Offered
  11.1.3 Pfizer Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Mallinckrodt
  11.2.1 Mallinckrodt Company Information
  11.2.2 Mallinckrodt Extended Release Drug Product Offered
  11.2.3 Mallinckrodt Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Mallinckrodt Main Business Overview
  11.2.5 Mallinckrodt Latest Developments
11.3 Teva
  11.3.1 Teva Company Information
  11.3.2 Teva Extended Release Drug Product Offered
  11.3.3 Teva Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Teva Main Business Overview
  11.3.5 Teva Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Extended Release Drug Product Offered
  11.4.3 Johnson & Johnson Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Endo Pharmaceuticals
  11.5.1 Endo Pharmaceuticals Company Information
  11.5.2 Endo Pharmaceuticals Extended Release Drug Product Offered
  11.5.3 Endo Pharmaceuticals Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Endo Pharmaceuticals Main Business Overview
  11.5.5 Endo Pharmaceuticals Latest Developments
11.6 Purdue Pharma
  11.6.1 Purdue Pharma Company Information
  11.6.2 Purdue Pharma Extended Release Drug Product Offered
  11.6.3 Purdue Pharma Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Purdue Pharma Main Business Overview
  11.6.5 Purdue Pharma Latest Developments
11.7 Mylan
  11.7.1 Mylan Company Information
  11.7.2 Mylan Extended Release Drug Product Offered
  11.7.3 Mylan Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Mylan Main Business Overview
  11.7.5 Mylan Latest Developments
11.8 Hisamitsu Pharmaceutical
  11.8.1 Hisamitsu Pharmaceutical Company Information
  11.8.2 Hisamitsu Pharmaceutical Extended Release Drug Product Offered
  11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Hisamitsu Pharmaceutical Main Business Overview
  11.8.5 Hisamitsu Pharmaceutical Latest Developments
11.9 Sun Pharmaceutical Industries
  11.9.1 Sun Pharmaceutical Industries Company Information
  11.9.2 Sun Pharmaceutical Industries Extended Release Drug Product Offered
  11.9.3 Sun Pharmaceutical Industries Extended Release Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sun Pharmaceutical Industries Main Business Overview
  11.9.5 Sun Pharmaceutical Industries Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Extended Release Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Extended Release Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sustained Release Drug
Table 4. Major Players of Controlled Release Drug
Table 5. Extended Release Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Extended Release Drug Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Extended Release Drug Market Size Market Share by Type (2020-2025)
Table 8. Extended Release Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Extended Release Drug Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Extended Release Drug Market Size Market Share by Application (2020-2025)
Table 11. Global Extended Release Drug Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Extended Release Drug Revenue Market Share by Player (2020-2025)
Table 13. Extended Release Drug Key Players Head office and Products Offered
Table 14. Extended Release Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Extended Release Drug Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Extended Release Drug Market Size Market Share by Region (2020-2025)
Table 19. Global Extended Release Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Extended Release Drug Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Extended Release Drug Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Extended Release Drug Market Size Market Share by Country (2020-2025)
Table 23. Americas Extended Release Drug Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Extended Release Drug Market Size Market Share by Type (2020-2025)
Table 25. Americas Extended Release Drug Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Extended Release Drug Market Size Market Share by Application (2020-2025)
Table 27. APAC Extended Release Drug Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Extended Release Drug Market Size Market Share by Region (2020-2025)
Table 29. APAC Extended Release Drug Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Extended Release Drug Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Extended Release Drug Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Extended Release Drug Market Size Market Share by Country (2020-2025)
Table 33. Europe Extended Release Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Extended Release Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Extended Release Drug Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Extended Release Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Extended Release Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Extended Release Drug
Table 39. Key Market Challenges & Risks of Extended Release Drug
Table 40. Key Industry Trends of Extended Release Drug
Table 41. Global Extended Release Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Extended Release Drug Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Extended Release Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Extended Release Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 46. Pfizer Extended Release Drug Product Offered
Table 47. Pfizer Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Mallinckrodt Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 51. Mallinckrodt Extended Release Drug Product Offered
Table 52. Mallinckrodt Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Mallinckrodt Main Business
Table 54. Mallinckrodt Latest Developments
Table 55. Teva Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 56. Teva Extended Release Drug Product Offered
Table 57. Teva Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Teva Main Business
Table 59. Teva Latest Developments
Table 60. Johnson & Johnson Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 61. Johnson & Johnson Extended Release Drug Product Offered
Table 62. Johnson & Johnson Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Latest Developments
Table 65. Endo Pharmaceuticals Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 66. Endo Pharmaceuticals Extended Release Drug Product Offered
Table 67. Endo Pharmaceuticals Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Endo Pharmaceuticals Main Business
Table 69. Endo Pharmaceuticals Latest Developments
Table 70. Purdue Pharma Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 71. Purdue Pharma Extended Release Drug Product Offered
Table 72. Purdue Pharma Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Purdue Pharma Main Business
Table 74. Purdue Pharma Latest Developments
Table 75. Mylan Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 76. Mylan Extended Release Drug Product Offered
Table 77. Mylan Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Mylan Main Business
Table 79. Mylan Latest Developments
Table 80. Hisamitsu Pharmaceutical Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 81. Hisamitsu Pharmaceutical Extended Release Drug Product Offered
Table 82. Hisamitsu Pharmaceutical Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Hisamitsu Pharmaceutical Main Business
Table 84. Hisamitsu Pharmaceutical Latest Developments
Table 85. Sun Pharmaceutical Industries Details, Company Type, Extended Release Drug Area Served and Its Competitors
Table 86. Sun Pharmaceutical Industries Extended Release Drug Product Offered
Table 87. Sun Pharmaceutical Industries Extended Release Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sun Pharmaceutical Industries Main Business
Table 89. Sun Pharmaceutical Industries Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Extended Release Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Extended Release Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Extended Release Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Extended Release Drug Sales Market Share by Country/Region (2024)
Figure 8. Extended Release Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Extended Release Drug Market Size Market Share by Type in 2024
Figure 10. Extended Release Drug in Hospital Pharmacy
Figure 11. Global Extended Release Drug Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Extended Release Drug in Retail Pharmacy
Figure 13. Global Extended Release Drug Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Extended Release Drug in Online Pharmacy
Figure 15. Global Extended Release Drug Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 16. Global Extended Release Drug Market Size Market Share by Application in 2024
Figure 17. Global Extended Release Drug Revenue Market Share by Player in 2024
Figure 18. Global Extended Release Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Extended Release Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Extended Release Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Extended Release Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Extended Release Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Extended Release Drug Value Market Share by Country in 2024
Figure 24. United States Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Extended Release Drug Market Size Market Share by Region in 2024
Figure 29. APAC Extended Release Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Extended Release Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Extended Release Drug Market Size Market Share by Country in 2024
Figure 38. Europe Extended Release Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Extended Release Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Extended Release Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Extended Release Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Extended Release Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Extended Release Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 61. China Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 65. India Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 68. France Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Extended Release Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Extended Release Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Extended Release Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Extended Release Drug Market Size 2026-2031 ($ millions)